The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

Feb. 23, 2015
Applicant:

Celgene Corporation, Summit, NJ (US);

Inventors:

Hiroshi Handa, Tokyo, JP;

Hideki Ando, Tokyo, JP;

Takumi Ito, Kanagawa, JP;

Assignee:

Celgene Corporation, Summit, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/30 (2015.01); G01N 33/48 (2006.01); G01N 33/50 (2006.01); C12N 5/0797 (2010.01); C12N 15/113 (2010.01); A61K 35/545 (2015.01); A61K 38/17 (2006.01); C12N 5/079 (2010.01); C12Q 1/6883 (2018.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/30 (2013.01); A61K 35/545 (2013.01); A61K 38/1709 (2013.01); C12N 5/0618 (2013.01); C12N 5/0623 (2013.01); C12N 15/113 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5088 (2013.01); A61K 48/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3233 (2013.01); C12N 2320/30 (2013.01); C12N 2501/60 (2013.01); C12N 2501/70 (2013.01); C12N 2501/998 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2828 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/52 (2013.01);
Abstract

Provided herein, for example, are methods generally relating to the expansion and/or regeneration of central nervous system (CNS) cells, such as nerve cells, astrocytes and oligodendrocytes, using an activator of cereblon (CRBN), such as an inhibitor of a CRBN substrate or downstream protein. Also provided herein, for example, are methods related to the expansion of neural stem cells, neural progenitor cells, or neural precursor cells and/or differentiation of these cells into CNS cells using a BRD7 antagonist, Ikaros antagonist, or CRBN activator. In certain embodiments, the methods further comprise differentiation of certain stem cells into the neural stem cells, neural progenitor cells, or neural precursor cells using a BRD7 antagonist, Ikaros antagonist, or CRBN activator. Also provided herein, for example, are methods of preventing or treating a CNS cell defective disease, disorder or condition, or a symptom thereof, using a BRD7 antagonist, Ikaros antagonist, or CRBN activator.


Find Patent Forward Citations

Loading…